Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital

 

Site:
Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital
Address:
 
City:
Amsterdam
State:
Zip:
1066 CX
Country:
Netherlands

 

6 trials at this site

 

 

3
Active, not recruiting
Active
QINLOCK Ripretinib DCC-2618 SUTENT Sunitinib
NCT03673501
3
Active, not recruiting
Closed
Imatinib
NCT02413736
3
Recruiting
Active
Bezuclastinib plus Sunitinib
NCT05208047
3
Terminated
Closed
Imatinib
NCT00956072
3
Unknown
Active
Masitinib or Sunitinib
NCT01694277
2
Unknown
Active
Imatinib + Regorafenib
NCT02365441